Waters Corporation $WAT Stock Holdings Increased by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. increased its stake in Waters Corporation (NYSE:WAT) by 106.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,751 shares of the medical instruments supplier’s stock after purchasing an additional 1,420 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in Waters were worth $1,045,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of WAT. SG Americas Securities LLC grew its stake in shares of Waters by 543.8% in the 4th quarter. SG Americas Securities LLC now owns 37,244 shares of the medical instruments supplier’s stock worth $14,146,000 after purchasing an additional 31,459 shares during the last quarter. Mackenzie Financial Corp boosted its holdings in Waters by 12.2% during the third quarter. Mackenzie Financial Corp now owns 231,852 shares of the medical instruments supplier’s stock worth $69,512,000 after buying an additional 25,182 shares in the last quarter. Banque Cantonale Vaudoise grew its position in Waters by 329.0% in the fourth quarter. Banque Cantonale Vaudoise now owns 4,294 shares of the medical instruments supplier’s stock worth $1,631,000 after buying an additional 3,293 shares during the last quarter. Nordea Investment Management AB grew its position in Waters by 15.8% in the fourth quarter. Nordea Investment Management AB now owns 13,550 shares of the medical instruments supplier’s stock worth $5,177,000 after buying an additional 1,848 shares during the last quarter. Finally, Graybill Wealth Management LTD. bought a new position in shares of Waters in the third quarter valued at $2,591,000. Institutional investors own 94.01% of the company’s stock.

Analysts Set New Price Targets

WAT has been the topic of a number of recent analyst reports. Wells Fargo & Company boosted their target price on Waters from $355.00 to $370.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 14th. Piper Sandler began coverage on Waters in a research report on Thursday, June 11th. They issued a “neutral” rating and a $400.00 price target for the company. Wolfe Research began coverage on Waters in a research note on Tuesday, June 2nd. They issued an “outperform” rating and a $425.00 price target on the stock. Robert W. Baird set a $387.00 price objective on Waters in a report on Wednesday, May 6th. Finally, Evercore raised shares of Waters from an “in-line” rating to an “outperform” rating and set a $350.00 price objective for the company in a research note on Monday, April 6th. Four analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, Waters has a consensus rating of “Moderate Buy” and a consensus target price of $396.68.

Waters Price Performance

NYSE WAT opened at $378.62 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.79 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $37.18 billion, a PE ratio of 48.11, a price-to-earnings-growth ratio of 2.29 and a beta of 1.20. Waters Corporation has a 12-month low of $275.05 and a 12-month high of $414.15. The company has a 50 day moving average price of $350.65 and a two-hundred day moving average price of $346.80.

Waters (NYSE:WAT) last posted its earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share for the quarter, beating the consensus estimate of $2.31 by $0.39. The company had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.20 billion. Waters had a return on equity of 15.60% and a net margin of 11.91%.The business’s revenue was up 91.4% compared to the same quarter last year. During the same period last year, the company earned $2.25 earnings per share. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. As a group, equities analysts predict that Waters Corporation will post 14.51 earnings per share for the current fiscal year.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.